Effects on Sperms' Quality of Selegiline in Aged Rats.

Q2 Pharmacology, Toxicology and Pharmaceutics
Open Medicinal Chemistry Journal Pub Date : 2017-11-30 eCollection Date: 2017-01-01 DOI:10.2174/1874104501711010138
Huba Kalász, Julianna Thuróczy, Gellért Karvaly, Lajos Balogh, István Gyertyán, Edit Tóth-Molnár, Ernest Adeghate, Kornélia Tekes
{"title":"Effects on Sperms' Quality of Selegiline in Aged Rats.","authors":"Huba Kalász,&nbsp;Julianna Thuróczy,&nbsp;Gellért Karvaly,&nbsp;Lajos Balogh,&nbsp;István Gyertyán,&nbsp;Edit Tóth-Molnár,&nbsp;Ernest Adeghate,&nbsp;Kornélia Tekes","doi":"10.2174/1874104501711010138","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Selegiline is used to treat Parkinsonian patients. Other indications of its use have recently been discovered.</p><p><strong>Objective: </strong>Scouting special and beneficial side effects of selegiline treatment.</p><p><strong>Method: </strong>Two-year old male Wistar rats were daily treated with 0.25 mg/kg of selegiline s.c. (subcutaneous injection). The rats were sacrificed following a four-weeks' treatment.</p><p><strong>Results: </strong>Mass of testes, number of sperms, progressive motility of sperms, and their viability definitely increased.</p><p><strong>Conclusion: </strong>Selegiline can successfully be used to stop/counterbalance certain symptoms of aging.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"138-145"},"PeriodicalIF":0.0000,"publicationDate":"2017-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748828/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Medicinal Chemistry Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874104501711010138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Selegiline is used to treat Parkinsonian patients. Other indications of its use have recently been discovered.

Objective: Scouting special and beneficial side effects of selegiline treatment.

Method: Two-year old male Wistar rats were daily treated with 0.25 mg/kg of selegiline s.c. (subcutaneous injection). The rats were sacrificed following a four-weeks' treatment.

Results: Mass of testes, number of sperms, progressive motility of sperms, and their viability definitely increased.

Conclusion: Selegiline can successfully be used to stop/counterbalance certain symptoms of aging.

Abstract Image

斯来吉兰对老龄大鼠精子质量的影响。
背景:斯来吉兰用于治疗帕金森病患者。最近还发现了使用它的其他迹象。目的:发现司来吉兰治疗的特殊有益副作用。方法:2岁雄性Wistar大鼠每日皮下注射0.25 mg/kg斯来吉兰s.c。这些大鼠在治疗四周后被处死。结果:睾丸质量、精子数量、精子进行性运动能力和活力明显提高。结论:司来吉兰可以成功地阻止/平衡某些衰老症状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Open Medicinal Chemistry Journal
Open Medicinal Chemistry Journal Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
4.40
自引率
0.00%
发文量
4
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信